Clinical Trial Update: Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for sequential immunotherapy combining anti-angiogenesis and chemotherapy in advanced gastroesophageal junction adenocarcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Harry H Yoon | Conditions: Gastric Cancer, GastroEsophageal Cancer | Phase 2 | Status: RECRUITING